Article Details
Retrieved on: 2025-04-11 13:49:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities has revised its price target for Globus Medical (GMED) from $82 to $80 while maintaining a Hold rating on the company's shares.
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here